approval
saveLINAGLIPTIN — FDA approval
November 3, 2025updated 5mo ago
community read0 votes
Sponsor: DR REDDYS. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalSYNJARDY: JARDIANCE (EMPAGLIFLOZIN) — FDA approvalOct 24, 2025
- approval(empagliflozin + metformin hydrochloride ER): SYNJARDY XR (EMPAGLIFLOZIN) — FDA approvalOct 24, 2025
- approval(empagliflozin + linagliptin + metformin hydrochloride) ER: TRIJARDY XR (EMPAGLIFLOZIN) — FDA approvalOct 24, 2025
- approval(empagliflozin + linagliptin): GLYXAMBI (EMPAGLIFLOZIN) — FDA approvalOct 24, 2025
- approvalSYNJARDY: SYNJARDY (EMPAGLIFLOZIN) — FDA approvalOct 24, 2025
- approvalspesolimab: SPEVIGO (SPESOLIMAB-SBZO) — FDA approvalOct 21, 2025
🐶 often sniffed alongside
top 8- tagApproval222 co-mentions · 111 sources
- drugTRIJARDY XR96 co-mentions · 89 sources
- tagSmall Molecule96 co-mentions · 95 sources
- drugSYNJARDY35 co-mentions · 35 sources
- drugempagliflozin26 co-mentions · 26 sources
- drugJARDIANCE26 co-mentions · 26 sources
- drugCYLTEZO24 co-mentions · 12 sources
- drugHUMIRA24 co-mentions · 12 sources
comments(0)
5-min edit window · permanent after that